Thursday, October 9, 2025

Transrail Lighting bags fresh ₹421-cr orders; FY26 order book crosses ₹3,500 crore

Date:

Mumbai-based Transrail Lighting Ltd, a leading turnkey EPC company in power transmission and distribution, has secured fresh orders worth ₹421 crore on Monday (September 15), including a major transmission line contract in a new African market.

“These additions have taken the Company’s FY26 order inflows beyond ₹3,500 crore as of August 2025, reflecting a growth of 78% Y-o-Y, ” the press release added.

“We are pleased to announce our expansion into a new country in Africa with a large transmission line order,” said Randeep Narang, MD & CEO of Transrail Lighting.

He added that the latest wins in international T&D and poles and lighting reflect the company’s diversified capabilities and growing global presence.

Last month, Narang had projected FY26 inflows to reach ₹9,500-10,000 crore, in line with last year’s performance.

The company is also advancing its capacity expansion programme, committing over ₹500 crore towards brownfield upgrades and a new greenfield tower project slated for completion by March 2026.

Narang reaffirmed confidence in achieving revenue growth guidance of 22–25% for the year, supported by accelerating project execution.

Also Read: Mishra Dhatu Nigam order book nears ₹2,000 cr with latest ₹136 cr win

Shares of Transrail Lighting Ltd ended higher on Monday (September 15) by 2.17% at ₹801 on the NSE.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Hungarian László Author Krasznahorkai Wins 2025 Nobel Prize in Literature

Hungarian novelist László Krasznahorkai won the 2025 Nobel Prize...

Diwali credit card rush: Are we celebrating prosperity or borrowing it?

जैसे-जैसे हम दिवाली की तैयारी कर रहे हैं, बैंकों...

Punjab & Sind Bank Q2 Update: Total business rises 12% to ₹2.41 lakh crore

State-owned Punjab & Sind Bank Ltd on Saturday (October...

Tariffs on generic drugs were always unlikely, exemption makes sense for all: Pharma Analyst

Pharma stocks were buzzing in trade on Thursday, October...